Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2026-02-24 @ 5:45 AM
Study NCT ID:
NCT04907851
Status:
COMPLETED
Last Update Posted:
2025-03-17
First Post:
2021-05-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2)
Sponsor:
Redx Pharma Ltd
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Solid Tumours | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Open-Label | View |
| None | RXC004 | View |
| None | Ring finger protein 43 | View |
| None | Pancreatic ductal adenocarcinoma | View |
| None | Biliary tract cancer | View |
| None | Efficacy | View |
| None | Safety | View |
| None | Pharmacokinetics | View |
| None | Pancreatic cancer | View |
| None | Cholangiocarcinoma | View |
| None | Gallbladder | View |
| None | Ampullary Cancer | View |
| None | Ampulla of Vater | View |
| None | MK-3475-E86 | View |
| None | zamaporvint | View |